Myriam Witvrouw

10.0k citations

192 papers · 8.1k indexed · h-index 53

Co-authors: Erik De Clercq Christophe Pannecouque Zeger Debyser Jan Balzarini Jan Desmyter Dominique Schols Robert Snoeck Graciela Andreï
Topics: HIV/AIDS drug development and treatment (155 papers)HIV Research and Treatment (120 papers)Biochemical and Molecular Research (27 papers)
Cited by: Virology Infectious Diseases Organic Chemistry
Journals: Proceedings of the National Academy of Sciences Nucleic Acids Research Journal of Biological Chemistry
Partner nations: Belgium France United States

In The Last Decade

Myriam Witvrouw

191 papers receiving 7.9k citations

Peers

Countries citing papers authored by Myriam Witvrouw

Since Specialization

Citations

This map shows the geographic impact of Myriam Witvrouw's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Myriam Witvrouw with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Myriam Witvrouw more than expected).

Fields of papers citing papers by Myriam Witvrouw

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Myriam Witvrouw. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Myriam Witvrouw. The network helps show where Myriam Witvrouw may publish in the future.

Co-authorship network of co-authors of Myriam Witvrouw

This figure shows the co-authorship network connecting the top 25 collaborators of Myriam Witvrouw. A scholar is included among the top collaborators of Myriam Witvrouw based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Myriam Witvrouw. Myriam Witvrouw is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Design, synthesis and antiHIV activity of novel isatine-sulphonamides 2008 ·Indian Journal of Pharmaceutical Sciences ·Parasuraman Selvam,N. Murugesh,(unknown),(unknown),Myriam Witvrouw	33
2	Toward novel HIV-1 integrase binding inhibitors: Molecular modeling, synthesis, and biological studies 2007 ·Bioorganic & Medicinal Chemistry Letters ·Claudia Mugnaini,(unknown),Cristina Tintori,Federico Corelli,Silvio Massa,Myriam Witvrouw,Zeger Debyser,Veljko Veljković,Maurizio Botta	24
3	Susceptibility of HIV-2, SIV and SHIV to various anti-HIV-1 compounds: Implications for treatment and postexposure prophylaxis 2004 ·Antiviral Research ·Myriam Witvrouw,Christophe Pannecouque,William M. Switzer,Thomas M. Folks,Erik De Clercq,Walid Heneine	1
4	Are 5′-O-Carbamate-2′,3′-dideoxythiacytidine New Anti-HIV and Anti-HBV nucleoside Drugs or Prodrugs? 2003 ·Bioorganic & Medicinal Chemistry Letters ·Carole Anastasi,Patrick Vlieghe,O. Hantz,Olivier Schorr,Christophe Pannecouque,Myriam Witvrouw,Erik De Clercq,Pascal Clayette,(unknown),Dominique Dormont,(unknown),Ivan Hirsch,Jean‐Louis Kraus	12
5	Antiviral resistance to diketo acids is associated with the mutations T66I, L74M and S230R in the HIV-1 integrase gene 2002 ·Antiviral Research ·Myriam Witvrouw,Valery Fikkert,Bénédicte Van Maele,Christophe Pannecouque,Nouri Neamati,Terrence R. Burke,Godwin C. G. Pais,Erik De Clercq,Zeger Debyser	1
6	New 2-(1-adamantylcarbonyl)pyridine and 1-acetyladamantane thiosemicarbazones–thiocarbonohydrazones: cell growth inhibitory, antiviral and antimicrobial activity evaluation 2002 ·Bioorganic & Medicinal Chemistry Letters ·Antonios Kolocouris,Kostas Dimas,Christophe Pannecouque,Myriam Witvrouw,George B. Foscolos,(unknown),George Fytas,Grigoris Zoidis,Nicolas Kolocouris,Graciela Andreï,Robert Snoeck,Erik De Clercq	55
7	SYNTHESIS AND BIOLOGICAL ACTIVITY OF 4-SUBSTITUTED 1-[1-(2-HYDROXYETHOXY)- METHYL-1,2,3-TRIAZOL-(4 & 5)-YLMETHYL]-1H-PYRAZOLO[3,4-d]PYRIMIDINES 2001 ·Nucleosides Nucleotides & Nucleic Acids ·Omar Moukha‐Chafiq,(unknown),Hassan B. Lazrek,Christophe Pannecouque,Myriam Witvrouw,Erik De Clercq,J. L. Barascut,Jean‐Louis Imbach	18
8	Antiviral, Haemolytic and Molluscicidal Activities of Triterpenoid Saponins from Maesa lanceolata: Establishment of Structure-Activity Relationships 2001 ·Planta Medica ·Sandra Apers,(unknown),(unknown),Myriam Witvrouw,Erik De Clercq,(unknown),Eric Van Marck,Arnold Vlietinck,Luc Pieters	48
9	Mutations in the non-nucleoside binding-pocket interfere with the multi-nucleoside resistance phenotype 2001 ·AIDS ·Kristel Van Laethem,Myriam Witvrouw,Christophe Pannecouque,Barbara Van Remoortel,Jean‐Claude Schmit,Robert Esnouf,Jőrg‐Peter Kleim,Jan Balzarini,Jan Desmyter,Erik De Clercq,Anne–Mieke Vandamme	16
10	Presence of 2' ,5'-Bis- O -( tert -butyldimethylsilyl)-3-spiro-5"(4"-amino-1",2"-oxathiole-2",2"-dioxide) (TSAO)-Resistant Virus Strains in TSAO-Inexperienced HIV Patients 2000 ·AIDS Research and Human Retroviruses ·Kristel Van Laethem,Jean‐Claude Schmit,Heidi Pelemans,Jan Balzarini,Myriam Witvrouw,María‐Jesús Pérez‐Pérez,Marı́a-José Camarasa,Robert Esnouf,Stefano Aquaro,Alessandra Cenci,Carlo Federico Perno	3
11	Studies on anti-HIV activity of Indigofera tinctoria 2000 ·Lirias (KU Leuven) ·S Kavimani,(unknown),Erik De Clercq,Christophe Pannecouque,Myriam Witvrouw	5
12	Viral Entry as the Primary Target for the Anti-HIV Activity of Chicoric Acid and Its Tetra-Acetyl Esters 2000 ·Molecular Pharmacology ·Wim Pluymers,(unknown),Christophe Pannecouque,(unknown),Christophe Marchand,Terrence R. Burke,Yves Pommier,Dominique Schols,Erik De Clercq,Zeger Debyser,Myriam Witvrouw	93
13	Activity of non-nucleoside reverse transcriptase inhibitors against HIV-2 and SIV 1999 ·AIDS ·Myriam Witvrouw,Christophe Pannecouque,Kristel Van Laethem,Jan Desmyter,Erik De Clercq,Anne–Mieke Vandamme	74
14	Anti-HIV-1 Activity of Combinations and Covalent Conjugates of Negatively Charged Human Serum Albumins (NCAs) and AZT 1999 ·Journal of drug targeting ·(unknown),Pieter Swart,Myriam Witvrouw,José A. Esté,D. Reymen,Erik De Clercq,Dirk K. F. Meijer	11
15	Anti-HIV Activity Of Some Mannich Bases Of Isatin Derivatives 1998 ·Indian Journal of Pharmaceutical Sciences ·(unknown),(unknown),Erik De Clercq,Christophe Pannecouque,Myriam Witvrouw	37
16	Multiple dideoxynucleoside analogue-resistant (MddNR) HIV-1 strains isolated from patients from different European countries 1998 ·AIDS ·Jean-Claude Schmit,Kristel Van Laethem,Lı́dia Ruiz,Philippe Hermans,S Sprecher,Anders Sönnerborg,Manuel Leal,Thomas Harrer,Bonaventura Clotet,Vic Arendt,Eduardo Lissen,Myriam Witvrouw,Jan Desmyter,Erik De Clercq,Anne–Mieke Vandamme	76
17	Synthesis of aryl semicarbazone of 4-aminoacetophenone and their anti-HIV activity 1998 ·Pharmaceutica Acta Helvetiae ·(unknown),S. N. Pandeya,Erik De Clercq,Christophe Pannecouque,Myriam Witvrouw	17
18	Conversion of 2′,3′‐dideoxyadenosine (ddA) and 2′,3′‐didehydro‐2′,3′‐dideoxyadenosine (d4A) to their corresponding aryloxyphosphoramidate derivatives markedly potentiates their activity against human immunodeficiency virus and hepatitis B virus 1997 ·FEBS Letters ·Jan Balzarini,J. Kruining,(unknown),Christophe Pannecouque,Stefano Aquaro,Carlo Federico Perno,Lieve Naesens,Myriam Witvrouw,Rudolf A. Heijtink,Erik De Clercq,Christopher McGuigan	53
19	Activity of the (R)-Enantiomers of 9-(2-Phosphonylmethoxypropyl)-Adenine and 9-(2-Phosphonylmethoxypropyl)-2,6-diaminopurine against Human Immunodeficiency Virus in Different Human Cell Systems 1996 ·Biochemical and Biophysical Research Communications ·Jan Balzarini,Stefano Aquaro,Carlo Federico Perno,Myriam Witvrouw,Antonı́n Holý,Erik De Clercq	77
20	Highly favorable antiviral activity and resistance profile of the novel thiocarboxanilide pentenyloxy ether derivatives UC-781 and UC-82 as inhibitors of human immunodeficiency virus type 1 replication. 1996 ·Molecular Pharmacology ·Jan Balzarini,Heidi Pelemans,Stefano Aquaro,Carlo Federico Perno,Myriam Witvrouw,Dominique Schols,Erik De Clercq,Anna Karlsson	49

About Myriam Witvrouw

Myriam Witvrouw is a scholar working on Virology, Infectious Diseases and Hepatology, having authored 192 papers that have together received 8.1k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (155 papers), HIV Research and Treatment (120 papers) and Biochemical and Molecular Research (27 papers). The work is most often cited by research in Virology (3.1k citations), Infectious Diseases (3.4k citations) and Organic Chemistry (2.7k citations). Myriam Witvrouw has collaborated with scholars based in Belgium, France and United States. Frequent co-authors include Erik De Clercq, Christophe Pannecouque, Zeger Debyser, Jan Balzarini, Jan Desmyter, Dominique Schols, Robert Snoeck, Graciela Andreï, Frauke Christ and Rudi Pauwels. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact